DE69131752T2 - Vitalethin und seine anwendung in zellkultur und therapie - Google Patents

Vitalethin und seine anwendung in zellkultur und therapie

Info

Publication number
DE69131752T2
DE69131752T2 DE69131752T DE69131752T DE69131752T2 DE 69131752 T2 DE69131752 T2 DE 69131752T2 DE 69131752 T DE69131752 T DE 69131752T DE 69131752 T DE69131752 T DE 69131752T DE 69131752 T2 DE69131752 T2 DE 69131752T2
Authority
DE
Germany
Prior art keywords
cells
compound
tumor
cell
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131752T
Other languages
German (de)
English (en)
Other versions
DE69131752D1 (de
Inventor
Galen Knight
Terence Scallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of New Mexico UNM
Original Assignee
University of New Mexico UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of New Mexico UNM filed Critical University of New Mexico UNM
Publication of DE69131752D1 publication Critical patent/DE69131752D1/de
Application granted granted Critical
Publication of DE69131752T2 publication Critical patent/DE69131752T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69131752T 1990-07-06 1991-07-08 Vitalethin und seine anwendung in zellkultur und therapie Expired - Fee Related DE69131752T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54910590A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06
PCT/US1991/004726 WO1992000955A1 (en) 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy

Publications (2)

Publication Number Publication Date
DE69131752D1 DE69131752D1 (de) 1999-12-02
DE69131752T2 true DE69131752T2 (de) 2000-06-29

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131752T Expired - Fee Related DE69131752T2 (de) 1990-07-06 1991-07-08 Vitalethin und seine anwendung in zellkultur und therapie

Country Status (9)

Country Link
EP (1) EP0539525B1 (enExample)
JP (1) JP3259960B2 (enExample)
AT (1) ATE186048T1 (enExample)
AU (1) AU655598B2 (enExample)
DE (1) DE69131752T2 (enExample)
DK (1) DK0539525T3 (enExample)
ES (1) ES2139580T3 (enExample)
GR (1) GR3031801T3 (enExample)
WO (1) WO1992000955A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718140B2 (en) * 1995-10-17 2000-04-06 Dovetail Technologies, Inc. Low molecular weight cell, bone marrow and immune stimulants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
JP3319597B2 (ja) * 1990-07-06 2002-09-03 ユニバシテイ オブ ニュー メキシコ 細胞培養及び治療に有用なβ―アレチン

Also Published As

Publication number Publication date
GR3031801T3 (en) 2000-02-29
DK0539525T3 (da) 2000-04-10
JPH06500106A (ja) 1994-01-06
JP3259960B2 (ja) 2002-02-25
HK1014367A1 (en) 1999-09-24
DE69131752D1 (de) 1999-12-02
EP0539525B1 (en) 1999-10-27
ES2139580T3 (es) 2000-02-16
ATE186048T1 (de) 1999-11-15
EP0539525A4 (enExample) 1994-01-12
AU655598B2 (en) 1995-01-05
AU8500891A (en) 1992-02-04
EP0539525A1 (en) 1993-05-05
WO1992000955A1 (en) 1992-01-23

Similar Documents

Publication Publication Date Title
DE3320342A1 (de) Reine einzelne faktoren 1, 2, 3, 4 und 5 von teichomycin a(pfeil abwaerts)2(pfeil abwaerts) und verfahren zu ihrer herstellung
DD156813A5 (de) Verfahren zur herstellung von estern von 9-hydroxyalkylpurinen
CH634599A5 (de) Verfahren zur herstellung von neuen antibiotika der thienamycin-reihe.
IL28164A (en) Substituted ammonium basic addition salts of ribonucleic acid and their preparation
DE69131752T2 (de) Vitalethin und seine anwendung in zellkultur und therapie
DE69113802T2 (de) Anwendung von beta-alethin in zellkultur und therapie.
RU2108100C1 (ru) Иммуномодулятор
US5370868A (en) Therapeutic use of vitaletheine modulators in neoplasia
DE68910397T2 (de) Vorbeugung oder Beseitigung von Mycoplasmakontamination in pflanzlichen oder tierischen Zellkulturen.
DE3752184T2 (de) Herstellung und Verwendungen von gamma-Interferon
EP0338308A2 (de) Substituierte N-Glycosylamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE69029315T2 (de) Verfahren zur Herstellung von Oxazopyrrolochinolinen, die sie enthaltenden Produkte und deren Verwendung
RU2191015C2 (ru) Динатриевая соль n-(6-метил-2,4-диоксо-1,2,3,4-тетрагидро-5h-пиримидинсульфон)-n'- изоникотиноилгидразида, проявляющая антимикробную и иммунотропную активность, и лекарственное средство на ее основе
Müller Influence of ionizing radiation on the appearance in the serum of rabbits of humoral factors slowing down cell division
HK1014367B (en) Vitaletheine and use in cell culture and therapy
DE3783511T2 (de) Verfahren zur zuechtung tierischer zellen und geeignete medien.
RU2228178C1 (ru) Иммунодепрессант
DE3883696T2 (de) Anti-Krebs-Mittel und Reagenz zur Gewinnung von Revertanten.
RU2422151C1 (ru) Препарат на основе гриба pleurotus 1137, влияющий на мужскую репродуктивную функцию
Goodpasture et al. The Protective Action of Rabbit Serum for Vaccinia Virus at High Temperatures
DE2136067A1 (de) Fluorierte Aminosäuren
DE1203423B (de) Verfahren zur Herstellung des Antibiotikums ZN-6 (Fusidinsaeure)
DE3249946C2 (de) hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
DE933053C (de) Verfahren zur Herstellung des Antibiotikums 106-7
DE2802277A1 (de) Verfahren zur herstellung eines gegen boesartiges wachstum gerichteten immunologischen wirkstoffkomplexes aus zellen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee